AstraZeneca upgraded at Danske

Shares of AstraZeneca (AZN +0.6%) are higher in morning trading.

Danske has upgraded the stock to Buy from Sell.

The move comes after the company provided a more optimistic forecast than many were expecting.

For more, see here and here.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs